Skip to content

Homeopathic medicines for weakness of cancer

Efficacy of individualized homoeopathic medicines in LM potencies in reducing cancer-related fatigue: A series of n-of-1 trials - Nil

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064438
Enrollment
21
Registered
2024-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: PCS-

Interventions

Intervention1: Individualized homeopathic medicines in LM potencies plus concomitant care: Intervention is planned as administering the indicated homeopathic medicine in 50 millesimal (LM) potencies.
7 doses are to be marked on the vial
each dose of 5 ml to be taken after 10 uniformly forceful downward strokes to the vial in 45 ml normal water in a clean cup, to stir well, to take 5 ml of this liquid orally, and to discard the rest o
each dose of 5 ml to be taken after 10 uniformly forceful downward strokes to the vial in 45 ml of normal water in a clean cup, Stir well, take 5 ml of this liquid orally, and discard the rest of the

Sponsors

D. N. De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from cancer-related fatigue (ICD-10 code R53.0) for at least 3 months 2. Patients who screen positively for fatigue (values of 4 out of 10 or higher indicating moderate to severe fatigue) 3. Age between 18 and 75 years 4. Either sex or transgender

Exclusion criteria

Exclusion criteria: 1. Patients who are not willing to cooperate and are not giving informed consent to participate in the trial. 2. Cases too sick for consultation. 3. Cases willing for or requiring immediate surgical intervention or undergoing major surgery in last 6 months 4. Diagnosed cases of uncontrolled systemic diseases, unstable mental or psychiatric illnesses, or other uncontrolled or life-threatening illness affecting quality of life or any organ failure 5. Patients with psychiatric disorders 6. Undergoing homoeopathic treatment for chronic disease within last 6 months 7. Substance abuse and/or dependence 8. Pregnant, puerperal and lactating women 9. Simultaneous participation in any other clinical trial

Design outcomes

Primary

MeasureTime frame
The Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F)Timepoint: Every 20 days, up to 2 months

Secondary

MeasureTime frame
The Short Form 36 (SF-36) Health Survey QuestionnaireTimepoint: Every 20 days, up to 2 months;The Wu Cancer Fatigue Scale (WCFS)Timepoint: Every 20 days, up to 2 months

Countries

India

Contacts

Public ContactProf Dr Shubhamoy Ghosh

D.N. De Homoeopathic Medical College and Hospital

Shubhamoy67@gmail.com9831034229

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026